Stock listing

Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H

Selected listing: 3378 · HKEX · HKD · HK

Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H (HKEX:3378), Health Technology. Latest release Jun 29, 2026: Next Day Disclosure Return.

3378:HKEXHKDHKUpdated October 2, 2026
Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H logo
Ticker
HKEX:3378
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

About Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H

The company focuses on biopharmaceuticals, contributing to advancements in healthcare. Investors can find relevant information about its operations and market performance on its public company page.

Latest news from Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H

Next Day Disclosure Return

June 29, 2026

VOLUNTARY ANNOUNCEMENT NOTICE ON VOLUNTARY EXTENSION OF LOCK-UP PERIOD BY SHAREHOLDERS

June 24, 2026

VOLUNTARY ANNOUNCEMENT INCLUSION OF HANX BIOPHARMACEUTICALS IN THE FTSE GLOBAL MICRO CAP INDEX

June 22, 2026

All Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H news →

Research Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H

Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H company profile

View the public company page for Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H on 6ix.

Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H news

Read company news and market updates connected to Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H.

Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H investor events

Find investor webinars, events, and replay context for Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H.